The majority of the gut microbiota is unculturable using standard laboratory techniques, which has been well-documented since the advent of next generation sequencing in microbiome research. This limitation makes it difficult to characterise the phenotype […]
PepsiCo, Inc. (NASDAQ: PEP) (“PepsiCo”) announced on Monday that it has entered into a definitive agreement to acquire poppi, a fast-growing prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a […]
Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that BL-001, an investigational oral therapy designed to replicate the positive effects of the ketogenic […]
With bacterial strains of the same species exhibiting remarkably different characteristics, it is vital biotic developers accurately characterise what strains are present in their product. This enables developers to maximise the biotics’ therapeutic potential, provide […]
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans, according to a team of researchers at Penn State. The […]